Výsledky vyhledávání - "Chittavanich P"

Akademický článek

Protocol for quantifying N-Myc and global protein translation in neuroblastoma cells using click chemistry on polyvinylidene fluoride membranes

Autor: Pamorn Chittavanich, Duangporn Saengwimol, Ariestya Indah Permata Sari, Atthapol Srimongkol, Rossukon Kaewkhaw

Publikováno v: STAR Protocols, Vol 5, Iss 4, Pp 103377- (2024)

Summary: MYCN amplification is a hallmark of aggressive neuroblastoma, driving N-Myc overexpression and enhancing protein synthesis, making these processes potential therapeutic targets. Here, we present a protocol for quantifying nascent N-Myc and g

Externí odkaz: https://doaj.org/article/e85952b636314204bce07191d5c52846

Zobrazit plný text záznamu

Akademický článek

Ceftriaxone exerts antitumor effects in MYCN‐driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression

Autor: Pamorn Chittavanich, Duangporn Saengwimol, Sittiruk Roytrakul, Duangnate Rojanaporn, Vijender Chaitankar, Atthapol Srimongkol, Usanarat Anurathapan, Suradej Hongeng, Rossukon Kaewkhaw

Publikováno v: Molecular Oncology, Vol 18, Iss 4, Pp 918-938 (2024)

MYCN proto‐oncogene, bHLH transcription factor (MYCN) amplification is associated with aggressive retinoblastoma (RB) and neuroblastoma (NB) cancer recurrence that is resistant to chemotherapies. Therefore, there is an urgent need to identify new t

Externí odkaz: https://doaj.org/article/838f6bba7dd247d2ac55f67737ffd727

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma

Autor: Duangporn Saengwimol, Duangnate Rojanaporn, Vijender Chaitankar, Pamorn Chittavanich, Rangsima Aroonroch, Tatpong Boontawon, Weerin Thammachote, Natini Jinawath, Suradej Hongeng, Rossukon Kaewkhaw

Publikováno v: Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)

Abstract Persistent or recurrent retinoblastoma (RB) is associated with the presence of vitreous or/and subretinal seeds in advanced RB and represents a major cause of therapeutic failure. This necessitates the development of novel therapies and thus

Externí odkaz: https://doaj.org/article/7055f181010d4848b2eaf2b999543e4e

Zobrazit plný text záznamu

Plný text ve formátu HTML